Literature DB >> 26120136

Primary care organisational interventions for secondary prevention of ischaemic heart disease: a systematic review and meta-analysis.

Edel Murphy1, Akke Vellinga1, Molly Byrne1, Margaret E Cupples2, Andrew W Murphy3, Brian Buckley4, Susan M Smith5.   

Abstract

BACKGROUND: Ischaemic heart disease (IHD) is the most common cause of death worldwide. AIM: To determine the long-term impact of organisational interventions for secondary prevention of IHD. DESIGN AND
SETTING: Systematic review and meta-analysis of studies from CENTRAL, MEDLINE(®), Embase, and CINAHL published January 2007 to January 2013.
METHOD: Searches were conducted for randomised controlled trials of patients with established IHD, with long-term follow-up, of cardiac secondary prevention programmes targeting organisational change in primary care or community settings. A random-effects model was used and risk ratios were calculated.
RESULTS: Five studies were included with 4005 participants. Meta-analysis of four studies with mortality data at 4.7-6 years showed that organisational interventions were associated with approximately 20% reduced mortality, with a risk ratio (RR) for all-cause mortality of 0.79 (95% confidence interval [CI] = 0.66 to 0.93), and a RR for cardiac-related mortality of 0.74 (95% CI = 0.58 to 0.94). Two studies reported mortality data at 10 years. Analysis of these data showed no significant differences between groups. There were insufficient data to conduct a meta-analysis on the effect of interventions on hospital admissions. Additional analyses showed no significant association between organisational interventions and risk factor management or appropriate prescribing at 4.7-6 years.
CONCLUSION: Cardiac secondary prevention programmes targeting organisational change are associated with a reduced risk of death for at least 4-6 years. There is insufficient evidence to conclude whether this beneficial effect is maintained indefinitely. © British Journal of General Practice 2015.

Entities:  

Keywords:  cardiovascular disease; coronary artery disease; general practice; systematic review

Mesh:

Year:  2015        PMID: 26120136      PMCID: PMC4484947          DOI: 10.3399/bjgp15X685681

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  20 in total

1.  Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action).

Authors:  M Campbell; J Grimshaw; N Steen
Journal:  J Health Serv Res Policy       Date:  2000-01

2.  Efficacy of case method learning in general practice for secondary prevention in patients with coronary artery disease: randomised controlled study.

Authors:  Anna Kiessling; Peter Henriksson
Journal:  BMJ       Date:  2002-10-19

3.  Case-based training of evidence-based clinical practice in primary care and decreased mortality in patients with coronary heart disease.

Authors:  Anna Kiessling; Moira Lewitt; Peter Henriksson
Journal:  Ann Fam Med       Date:  2011 May-Jun       Impact factor: 5.166

4.  Randomised trials of secondary prevention programmes in coronary heart disease: systematic review.

Authors:  F A McAlister; F M Lawson; K K Teo; P W Armstrong
Journal:  BMJ       Date:  2001-10-27

5.  Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care.

Authors:  Peter Murchie; Neil C Campbell; Lewis D Ritchie; Julie A Simpson; Joan Thain
Journal:  BMJ       Date:  2003-01-11

6.  The importance of making explicit links between theoretical constructs and behaviour change techniques.

Authors:  Susan Michie; Thomas L Webb; Falko F Sniehotta
Journal:  Addiction       Date:  2010-11       Impact factor: 6.526

Review 7.  The behaviour change wheel: a new method for characterising and designing behaviour change interventions.

Authors:  Susan Michie; Maartje M van Stralen; Robert West
Journal:  Implement Sci       Date:  2011-04-23       Impact factor: 7.327

8.  Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial.

Authors:  A W Murphy; M E Cupples; S M Smith; M Byrne; M C Byrne; J Newell
Journal:  BMJ       Date:  2009-10-29

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

10.  Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations.

Authors:  Judith A Finegold; Perviz Asaria; Darrel P Francis
Journal:  Int J Cardiol       Date:  2012-12-04       Impact factor: 4.164

View more
  7 in total

1.  Secondary prevention of coronary artery disease in Poland. Results from the POLASPIRE survey.

Authors:  Piotr Jankowski; Dariusz A Kosior; Paweł Sowa; Karolina Szóstak-Janiak; Paweł Kozieł; Agnieszka Krzykwa; Emilia Sawicka; Maciej Haberka; Małgorzata Setny; Karol Kamiński; Zbigniew Gąsior; Aldona Kubica; Dirk De Bacquer; Guy De Backer; Kornelia Kotseva; David Wood; Andrzej Pająk; Danuta Czarnecka
Journal:  Cardiol J       Date:  2020-05-21       Impact factor: 2.737

2.  Impact of coronary heart disease on cognitive decline in Alzheimer's disease: a prospective longitudinal cohort study in primary care.

Authors:  Markus Bleckwenn; Luca Kleineidam; Michael Wagner; Frank Jessen; Siegfried Weyerer; Jochen Werle; Birgitt Wiese; Dagmar Lühmann; Tina Posselt; Hans-Helmut König; Christian Brettschneider; Edelgard Mösch; Dagmar Weeg; Angela Fuchs; Michael Pentzek; Tobias Luck; Steffi G Riedel-Heller; Wolfgang Maier; Martin Scherer
Journal:  Br J Gen Pract       Date:  2016-12-19       Impact factor: 5.386

3.  Rehabilitation of patients after transient ischaemic attack or minor stroke: pilot feasibility randomised trial of a home-based prevention programme.

Authors:  Neil Heron; Frank Kee; Jonathan Mant; Margaret E Cupples; Michael Donnelly
Journal:  Br J Gen Pract       Date:  2019-09-26       Impact factor: 5.386

Review 4.  Enhancing prescribing of guideline-recommended medications for ischaemic heart diseases: a systematic review and meta-analysis of interventions targeted at healthcare professionals.

Authors:  Thang Nguyen; Hoa Q Nguyen; Niken N Widyakusuma; Thao H Nguyen; Tam T Pham; Katja Taxis
Journal:  BMJ Open       Date:  2018-01-10       Impact factor: 2.692

5.  Practice setting and secondary prevention of coronary artery disease.

Authors:  Piotr Jankowski; Danuta Czarnecka; Leszek Badacz; Piotr Bogacki; Jacek S Dubiel; Janusz Grodecki; Tomasz Grodzicki; Janusz Maciejewicz; Ewa Mirek-Bryniarska; Jadwiga Nessler; Wiesław Piotrowski; Piotr Podolec; Wanda Śmielak-Korombel; Wiesława Tracz; Kalina Kawecka-Jaszcz; Andrzej Pająk
Journal:  Arch Med Sci       Date:  2017-01-19       Impact factor: 3.318

6.  Outcomes of Secondary Prevention among Coronary Heart Disease Patients in a High-Risk Region in Finland.

Authors:  Teppo Repo; Markku Tykkyläinen; Juha Mustonen; Tuomas T Rissanen; Matti Ketonen; Maija Toivakka; Tiina Laatikainen
Journal:  Int J Environ Res Public Health       Date:  2018-04-11       Impact factor: 3.390

7.  General practitioners' perspectives on the prevention of cardiovascular disease: systematic review and thematic synthesis of qualitative studies.

Authors:  Irene Ju; Emily Banks; Bianca Calabria; Angela Ju; Jason Agostino; Rosemary J Korda; Tim Usherwood; Karine Manera; Camilla S Hanson; Jonathan C Craig; Allison Tong
Journal:  BMJ Open       Date:  2018-11-01       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.